Antimicrobial usage among hospitalized children in Latvia: A neonatal and pediatric antimicrobial point prevalence survey

Medicina (Lithuania)

Volumn 50, Issue 3, 2014, Pages 175-181

  Sviestina, Inese ^a,b   Mozgis, Dzintars ^b  

^a CHILDREN'S CLINICAL UNIVERSITY HOSPITAL   (Latvia)

^b RIGA STRADINS UNIVERSITY   (Latvia)

Author keywords

Hospitalized children; Parenteral antibiotics; Point prevalence survey; Third generation cephalosporins

Indexed keywords

ANTIINFECTIVE AGENT;

ADOLESCENT; CHILD; CLASSIFICATION; CROSS-SECTIONAL STUDY; DRUG UTILIZATION; FEMALE; HOSPITALIZED CHILD; HUMAN; INFANT; LATVIA; MALE; PRESCHOOL CHILD; PREVALENCE; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, HOSPITALIZED; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; HUMANS; INFANT; LATVIA; MALE; PREVALENCE;

EID: 84907951717     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.medici.2014.08.005     Document Type: Article

References (30)

1. Spyridis N., Sharland M. The European Union Antibiotic Awareness Day: the paediatric perspective. Arch Dis Child 2008, 93:909-910.
2. de Jong J., van den Berg P.B., Visser S.T., de Vries T.W., de Jong-van den Berg L.T. Antibiotic usage, dosage and course length in children between 0 and 4 years. Acta Paediatr 2009, 98(7):1142-1148.
3. Gerber J.S., Newland J.G., Coffin S.E., Hall M., Thurm C., Prasad P.A., et al. Variability in antibiotic use at children's hospitals. Pediatrics 2010, 126:1067-1073.
4. Frank U., Kleissle E.M., Daschner F.D., Leibovici L., Paul M., Andreassen S., et al. Multicentre study of antimicrobial resistance and antibiotic consumption among 6780 patients with bloodstream infections. Eur J Clin Microbiol Infect Dis 2006, 25:815-817.
5. Hulscher M.E., Grol R.P., van der Meer J.W. Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis 2010, 10(3):167-175.
6. European Parliament resolution of 11 December 2012 on the Microbial Challenge - Rising threats from Antimicrobial Resistance. Available from (cited 29.01.13). http://www.europarl.europa.eu/sides/getDoc.do%3FpubRef=-//EP//TEXT+TA+P7-TA-2012-0483+0+DOC+XML+V0//EN.
7. Council of the European Union Council recommendation of 15 November 2001 on the prudent use of antimicrobial agents in human medicine (2002/77/EC). Off J Eur Commun L34 2002, 45:13-16. Available from http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2002:034:0013:0016:EN:PDF (cited 11.05.12).
8. Zarb P., Amadeo B., Muller A., Drapier N., Vankerckhoven V., Davey P., et al. Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009. J Antimicrob Chemother 2011, 66(2):443-449.
9. Zarb P., Goossens H. European Surveillance of Antimicrobial Consumption (ESAC): value of a point-prevalence survey of antimicrobial use across Europe. Drugs 2011, 71(6):745-755.
10. Malcolm W., Nathwani D., Davey P., Cromwell T., Patton A., Reilly J., et al. From intermittent antibiotic point prevalence surveys to quality improvement: experience in Scottish hospitals. Antimicrob Resist Infect Control 2013, 2(1):3.
11. Dimiņa E., Kula M., Caune U., Vigante D., Liepiņš M., Zeidaka L., et al. Repeated prevalence studies on antibiotic use in Latvia, 2003-2007. Euro Surveill 2009, 14(33). pii: 19307.
12. Amadeo B., Zarb P., Muller A., Drapier N., Vankerckhoven V., Rogues A.M., et al. European Surveillance of Antibiotic Consumption (ESAC) point prevalence survey 2008: paediatric antimicrobial prescribing in 32 hospitals of 21 European countries. J Antimicrob Chemother 2010, 65(10):2247-2252.
13. Versporten A., Sharland M., Bielicki J., Drapier N., Vankerckhoven V., Goossens H. The antibiotic resistance and prescribing in European children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide. Pediatr Infect Dis J 2013, 32(6):e242-e253. for the ARPEC Project Group Members.
14. Pediatric Point Prevalence Survey (ARPEC). Available from (cited 21.06.13). http://links.lww.com/INF/B548.
15. Neonatal Point Prevalence Survey (ARPEC). Available from (cited 21.06.13). http://links.lww.com/INF/B549.
16. European Centre for Disease Prevention and Control Surveillance of antimicrobial consumption in Europe 2010 2013, ECDC, Stockholm.
17. European Centre for Disease Prevention and Control Antimicrobial resistance surveillance in Europe 2010. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2011, The Centre, Stockholm.
18. Meyer E., Gastmeier P., Deja M., Schwab F. Antibiotic consumption and resistance: data from Europe and Germany. Int J Med Microbiol 2013, 303(6-7):388-395.
19. Meyer E., Schwab F., Schroeren-Boersch B., Gastmeier P. Dramatic increase of third generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Crit Care 2010, 14:R113.
20. Department of Health Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI) Antimicrobial stewardship: "Start Smart - then Focus". Guidance for antimicrobial stewardship in hospitals (England) 2011, Department of Health, London.
21. Sviestina I., Aston J., Mozgis D.z. Comparison of antimicrobial prescribing between two specialist paediatric centres in the UK and Latvia. Eur J Hosp Pharm 2013, 20:180-184.
22. Malik B.A., Xie Y.Y., Wine E., Huynh H.Q. Diagnosis and pharmacological management of small intestinal bacterial overgrowth in children with intestinal failure. Can J Gastroenterol 2011, 25(1):41-45.
23. Rojas M.X., Granados C. Oral antibiotics versus parenteral antibiotics for severe pneumonia in children. Cochrane Database Syst Rev 2006, 2:CD004979.
24. Lorgelly P.K., Atkinson M., Lakhanpaul M., Smyth A.R., Vyas H., Weston V., et al. Oral versus i.v. antibiotics for community-acquired pneumonia in children: a cost-minimisation analysis. Eur Respir J 2010, 35(4):858-864.
25. Vouloumanou E.K., Rafailidis P.I., Kazantzi M.S., Athanasiou S., Falagas M.E. Early switch to oral versus intravenous antimicrobial treatment for hospitalized patients with acute pyelonephritis: a systematic review of randomized controlled trials. Curr Med Res Opin 2008, 24(12):3423-3434.
26. Voit S.B., Todd J.K., Nelson B., Nyquist A.C. Electronic surveillance system for monitoring surgical antimicrobial prophylaxis. Pediatrics 2005, 116(6):1317-1322.
27. Ceyhan M., Yildirim I., Ecevit C., Aydogan A., Ornek A., Salman N., et al. Inappropriate antimicrobial use in Turkish pediatric hospitals: a multicenter point prevalence survey. Int J Infect Dis 2010, 14(1):e55-e61.
28. Robert J., Péan Y., Varon E., Bru J.-P, Bedos J.-P, Bertrand X., et al. Point prevalence survey of antibiotic use in French hospitals in 2009. J Antimicrob Chemother 2012, 67:1020-1026.
29. Rangel S.J., Fung M., Graham D.A., Ma L., Nelson C.P., Sandora T.J. Recent trends in the use of antibiotic prophylaxis in pediatric surgery. J Pediatr Surg 2011, 46:366-371.
30. Hing W.C., Yeoh T.T., Yeoh S.F., Lin R.T., Li S.C. An evaluation of antimicrobial prophylaxis in paediatric surgery and its financial implication. J Clin Pharm Ther 2005, 30(4):371-381.